Perspective Therapeutics
CATX
18 hedge funds and large institutions have $796K invested in Perspective Therapeutics in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.27% less ownership
Funds ownership: 0.68% → 0.41% (-0.27%)
53% less capital invested
Capital invested by funds: $1.71M → $796K (-$911K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.5K |
| 2 |
NES
New England Securities
New York
|
+$15.8K |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$890 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$880 |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$211 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$549K |
| 2 |
CWM
Concert Wealth Management
San Jose,
California
|
-$27K |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$13K |
| 4 |
U
UBS
Zurich,
Switzerland
|
-$1K |
CATX Hedge Fund Activity: Q4 2013 in Review
18 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2013, worth a combined $796K — down 53% from $1.71M a quarter earlier.
Fund positioning in CATX was balanced in Q4 2013: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $18.5K. The largest seller was Sabby Management, cutting an estimated $549K.
- 18 institutional investors held Perspective Therapeutics (CATX) as of Q4 2013, unchanged from Q3 2013.
- Funds reported $796K of Perspective Therapeutics stock for Q4 2013, down 53% quarter-over-quarter.
- 3 funds opened new Perspective Therapeutics positions in Q4 2013 and 3 closed out, a net change of 0 holders.
- The largest Perspective Therapeutics buyer in Q4 2013 was Citadel Advisors, an estimated $18.5K added.
- The largest Perspective Therapeutics seller in Q4 2013 was Sabby Management, an estimated $549K sold.
Based on aggregated 13F filings for Q4 2013.